[email protected]
CAS 62621-13-0 (D-SER4)-LEUPROLIDE molecular structure lightbox
CAS RN: 62621-13-0

(D-SER4)-LEUPROLIDE

Product Availability

Available package options are listed below.

1 package records0 with current stock
Batch No.PackageAvailabilityLead TimeInquiry
Batchno.20250805 10mg Out of stock 15 business days Inquiry
  • Product code: starshine_CAS62621-13-0
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

62621-13-0 / N-[1-[[1-[[1-[[1-[[1-[[1-[[5-(diaminomethylideneamino)-1-[2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide

Standard CAS: 62621-13-0 Multi CAS: Yes
Basic Information Computed Properties

Basic Information

CAS
62621-13-0
Multi CAS
Yes
Molecular Formula
C59H84N16O12
Molecular Weight
1209.400000
Exact Mass
1208.645462
InChI
InChI=1S/C59H84N16O12/c1-6-63-57(86)48-14-10-22-75(48)58(87)41(13-9-21-64-59(60)61)68-51(80)42(23-32(2)3)69-52(81)43(24-33(4)5)70-53(82)44(25-34-15-17-37(77)18-16-34)71-56(85)47(30-76)74-54(83)45(26-35-28-65-39-12-8-7-11-38(35)39)72-55(84)46(27-36-29-62-31-66-36)73-50(79)40-19-20-49(78)67-40/h7-8,11-12,15-18,28-29,31-33,40-48,65,76-77H,6,9-10,13-14,19-27,30H2,1-5H3,(H,62,66)(H,63,86)(H,67,78)(H,68,80)(H,69,81)(H,70,82)(H,71,85)(H,72,84)(H,73,79)(H,74,83)(H4,60,61,64)/t40-,41-,42-,43+,44-,45-,46-,47+,48-/m0/s1
InChIKey
GFIJNRVAKGFPGQ-WQVASJQXSA-N

Computed Properties

Structural Parameters

Heavy atom count
87
Aromatic heavy atom count
20
Fraction Csp3
0.53
Rotatable bonds
32
H-bond acceptors
14
H-bond donors
15
Molar refractivity
320.11
TPSA
431.54

LogP / Solubility

WLOGP
-1.44
MLOGP
-1.14
XLogP3
0.7
Consensus LogP
-0.63
Log S (ESOL)
-4.49
Class (ESOL)
Slightly soluble
Log S (Ali)
-8.44
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-10.17
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-11.12

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
10

Customers Also Viewed

Get In Touch

Contact Us